Submission Details
| 510(k) Number | K211585 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 24, 2021 |
| Decision Date | July 29, 2022 |
| Days to Decision | 431 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K211585 is an FDA 510(k) clearance for the Bodyport Cardiac Scale, a Plethysmograph, Impedance (Class II — Special Controls, product code DSB), submitted by Bodyport, Inc. (San Francisco, US). The FDA issued a Cleared decision on July 29, 2022, 431 days after receiving the submission on May 24, 2021. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2770.
| 510(k) Number | K211585 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 24, 2021 |
| Decision Date | July 29, 2022 |
| Days to Decision | 431 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DSB — Plethysmograph, Impedance |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2770 |